IN8bio, Inc.

NASDAQ:INAB

0.2254 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 0000000
Cost of Revenue 02.5011.1030.2510.0960.0960.096
Gross Profit 0-2.501-1.103-0.251-0.096-0.096-0.096
Gross Profit Ratio 0000000
Reseach & Development Expenses 16.96216.82714.0627.3475.3782.3580.581
General & Administrative Expenses 12.63713.5114.4597.3063.1792.7081.423
Selling & Marketing Expenses 0000000
SG&A 12.63713.5114.4597.3063.1792.7081.423
Other Expenses 1.06800000-0.063
Operating Expenses 30.66730.33728.52114.6538.5575.0662.004
Operating Income -30.437-30.337-28.521-14.653-8.557-5.134-2.004
Operating Income Ratio 0000000
Total Other Income Expenses Net 00.330000-0.077
Income Before Tax -30.437-30.007-28.521-14.653-8.557-5.134-2.081
Income Before Tax Ratio 0000000
Income Tax Expense 00-1.1030.551-0.118-0.068-0.063
Net Income -30.437-30.007-27.418-14.653-8.557-5.134-2.081
Net Income Ratio 0000000
EPS -0.57-1-1.31-0.78-0.44-0.27-0.34
EPS Diluted -0.57-1-1.31-0.78-0.44-0.27-0.34
EBITDA -30.437-28.504-27.418-14.402-8.469-5.038-1.971
EBITDA Ratio 0000000